The subject of dialyzer reuse continues to generate heated controversy as opposing interest groups expound widely divergent points of view, Users of dialyzers point to the advantages derived if an expensive item that is normally discarded can be reused without untoward effect or loss of efficiency. The manufacturers, on the other hand, insist that theirs is a product made according to strict quality control standards of chemical and bacteriological safety, and argue that reusing dialyzers does not meet these standards. The major issue is clearly one of economics, and in many parts of the world the users have apparently made their decision. Dialyzers are widely reused in the United States (1) and Europe, though not in Japan. Impressive savings can be achieved. In a unit treating some 45 patients, Mathew has reported savings of $ 85,000 per year (2), In our unit, where 220 patients are being dialyzed, we have reported savings of $ 600,000 (3) .
While proponents of dialyzer reuse have emphasized that cost containment is the basic reason for this practice, its opponents may have incorrectly focused on dialyzer efficiency rather than on safety. Standards of quality control throughout the United States have varied widely, and not all dialysis units have paid sufficient attention to the risks of dialyzed contamination. It would seem only reasonable to expect dialysis units to maintain the same quality control measures as are demanded from the original manufacturers, including an efficient monitoring system and bacteriological analysis of a fraction of all dialyzers cleaned. When this has been done, the prevalence of contamination with pathogenic organisms has been extremely low.
Similarly, a recent study by the Center for Disease Control and Dr. Norman Deane has shown that reusing dialyzers has not caused the spread of hepatitis (4). Bacterial contamination, recently emphasized in a report by the Health Industry Manufacturers Association (5) , has occurred only with poor techniques, use of inefficient sterilizing agents such as benzalkonium chloride or hydrogen peroxide, or following attempts to reuse coils and plateswhich inherently are not as easy to sterilize as are hollow fiber dialyzers.
Another point of concern has been the possible effect 4 of exposure to formaldehyde. This substance, preferred over other sterilizing agents because of the powerful chemical effects of its vapor and liquid states, could endanger both the patient and the reuse technicians. With regard to patient exposure, the use of the Schiff reagent allows formaldehyde to be detected at a concentration of about 5 micrograms/ml (5) . At this concentration the development of anti-N antibodies and antibody to formaldehyde-treated erythrocytes is less likely to occur. Potential dangers to the technician may be more difficult to deal with. Basal cell carcinoma has been reported in rodents exposed to formafehyde, but at higher concentrations than would normally be experienced in a dialysis unit (4) . Allergic responses to formaldehyde also occur. Until better sterilants are available, the use of efficient ventilation systems and the wearing of masks and protective clothing are required, and with the development of automatic reuse machines, this problem may become less important. l,Jntil then, of the various manual techniques currently in use for cleaning dialyzer, reverse ultrafiltration is preferred over more complex techniques (7). The water used should contain less than 200 colonies of bacteria/ml (7). Although the Health Industry Manufacturers Association report claims that a reduction in dialyzer performance may occur with reuse, many publications have refuted this, provided that cleaning is preformed under proper conditions (4, 7). Solutions that may damage fibers, such as bleach, must not be used, and the pressure limits should be maintained to prevent leaks. More difficult is the choice of criteria for discarding used dialyzers. Deane reported a good correlation between the measured volume of the dialyzer and its clearance, but no correlation between the latter and measured ultrafiltration rate (7). Techniques more accurate than measured volume are required.
An important recommendation of the Health Industry Manufacturers Association report was that a controlled study of morbidity and mortality in patients treated with first use or reuse dialyzers should be carried out. Kant et al have now clearly shown that reuse is not associated with an increase in morbidity (9) ; and the double blind trial by Bok et al have shown that, if anything, first use dialysis causes more symptoms than reuse (10) .
The National Kidney Foundation has recently stated its position on the legal, economic, medical, and ethical aspects of dialyzer reuse. There appears to be no legal ruling on reuse in the U.S.A., and, as matters presently stand, there is a rapid trend towards acceptance of this practice. An earlier order by the United States Veterans' Administration banning reuse in its hospitals was rapidly rescinded when evidence was presented that this would greatly increase costs. It now appears likely that financial pressures will encourage the spread of reuse in the Un-ited States, This could have a major impact on manufacturers, because the lack of growth in sales could hardly be offset by increasing the price of the dialyzer. One consequence of this would be that dialyzers would become too expensive for units that do not reuse, and force an increase in the number of reuses in units that do. Eventually this could provide a stimulus for the production of inexpensive disposable dialybers. Meanwhile, since widespread reuse seems likely to continue, we recommend strongly that it be carried out under the safest possible conditions, and that the highest standards of quality control be enforced.
Eosinophils, found predominantly in the skin and in intestinal or respiratory mucosa, playa prominent role in parasitic infections. They are mobilized to the site of an immediate hypersensitivity reaction, where they appear to dampen or inhibit IgE mediated hypersensitivity reactions (4) . Their other actions are similar to those of neutrophils. Eosinophilia usually indicates a secondary response rather than a primary process.
Various textbooks agree that eosinophil counts below 350/mm 3 are normal and above 550/mm 3 abnormal (1); values between 350/mm 3 and 550/mm 3 appear open to interpretation. The situation is complicated because of diurnal variations, with an evening peak and a morning nadir, and because stress and exercise raise the eosinophil count. Furthermore, the usual differential smears counting 100 white blood cells introduce quite a large error when used to calculate the total eosinophil count per mrn-, These considerations are important in evaluating dialysis eosinophilia. Its definition has varied from> 3551 rnrn ' or > 5% (5) to > 400/mm 3 (3, 8) to > 450/mm 3 (15) 
